These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential effect of short- and long-term lithium treatment on m-CPP-induced neuroendocrine changes in rats. Aulakh CS; Hill JL; Murphy DL Neuroendocrinology; 1993 May; 57(5):869-74. PubMed ID: 8413823 [TBL] [Abstract][Full Text] [Related]
3. Long-term imipramine treatment potentiates m-chlorophenylpiperazine-induced changes in prolactin but not corticosterone or growth hormone levels in rats. Aulakh CS; Haass M; Zohar J; Wozniak KM; Hill JL; Murphy DL Pharmacol Biochem Behav; 1989 Jan; 32(1):37-42. PubMed ID: 2734349 [TBL] [Abstract][Full Text] [Related]
4. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats. Aulakh CS; Hill JL; Murphy DL J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690 [TBL] [Abstract][Full Text] [Related]
5. Differential effect of clomipramine treatment on m-chlorophenylpiperazine-induced increases in plasma prolactin and corticosterone in rats. Wozniak KM; Aulakh CS; Hill JL; Murphy DL Pharmacol Biochem Behav; 1989 May; 33(1):265-7. PubMed ID: 2780783 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of antidepressant treatments on fenfluramine-induced increases in plasma prolactin and corticosterone in rats. Aulakh CS; Zohar J; Wozniak KM; Hill JL; Haass M; Murphy DL Pharmacol Biochem Behav; 1991 May; 39(1):91-5. PubMed ID: 1924518 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of long-term antidepressant treatments on 8-OHDPAT-induced increases in plasma prolactin and corticosterone in rats. Aulakh CS; Wozniak KM; Hill JL; Murphy DL Eur J Pharmacol; 1988 Nov; 156(3):395-400. PubMed ID: 2975226 [TBL] [Abstract][Full Text] [Related]
8. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Aulakh CS; Wozniak KM; Hill JL; Devane CL; Tolliver TJ; Murphy DL Neuroendocrinology; 1988 Oct; 48(4):401-6. PubMed ID: 2463494 [TBL] [Abstract][Full Text] [Related]
9. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Mueller EA; Murphy DL; Sunderland T Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595 [TBL] [Abstract][Full Text] [Related]
10. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Ulrichsen J; Partilla JS; Dax EM Psychopharmacology (Berl); 1992; 107(2-3):229-35. PubMed ID: 1352053 [TBL] [Abstract][Full Text] [Related]
11. [Effect of clorgyline and of alpha-methyl-p-tyrosine on the plasma levels of corticosterone in the rat]. Pinilla J; Montilla P; Clavero R Rev Esp Fisiol; 1985 Dec; 41(4):411-6. PubMed ID: 2869553 [TBL] [Abstract][Full Text] [Related]
12. Repeated administration of meta-chlorophenylpiperazine or 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane produces tolerance to its stimulatory effect on adrenocorticotropin hormone but not prolactin or corticosterone secretion in rats. Mazzola-Pomietto P; Aulakh CS; Huang SJ; Murphy DL J Pharmacol Exp Ther; 1996 Nov; 279(2):782-9. PubMed ID: 8930184 [TBL] [Abstract][Full Text] [Related]
13. Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion. Bero LA; Kuhn CM J Pharmacol Exp Ther; 1987 Mar; 240(3):825-30. PubMed ID: 3031276 [TBL] [Abstract][Full Text] [Related]
14. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder. Pigott TA; Zohar J; Hill JL; Bernstein SE; Grover GN; Zohar-Kadouch RC; Murphy DL Biol Psychiatry; 1991 Mar; 29(5):418-26. PubMed ID: 2018816 [TBL] [Abstract][Full Text] [Related]
15. Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine. Cohen RM; Aulakh CS; Murphy DL Eur J Pharmacol; 1983 Oct; 94(1-2):175-9. PubMed ID: 6653658 [TBL] [Abstract][Full Text] [Related]
16. Role of various 5-HT receptor subtypes in mediating neuroendocrine effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) in rats. Aulakh CS; Mazzola-Pomietto P; Hill JL; Murphy DL J Pharmacol Exp Ther; 1994 Oct; 271(1):143-8. PubMed ID: 7965707 [TBL] [Abstract][Full Text] [Related]
17. Long-term lithium treatment in rats attenuates m-chlorophenylpiperazine-induced decreases in food intake but not locomotor activity. Aulakh CS; Zohar J; Wozniak KM; Hill JL; Murphy DL Psychopharmacology (Berl); 1989; 98(4):448-52. PubMed ID: 2505284 [TBL] [Abstract][Full Text] [Related]
18. Long-term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in the rat. Bagdy G; Calogero AE; Aulakh CS; Szemeredi K; Murphy DL Neuroendocrinology; 1989 Sep; 50(3):241-7. PubMed ID: 2552339 [TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Aloi JA; Insel TR; Mueller EA; Murphy DL Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733 [TBL] [Abstract][Full Text] [Related]
20. Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT2C receptor levels in the rat. Fone KC; Austin RH; Topham IA; Kennett GA; Punhani T Br J Pharmacol; 1998 Apr; 123(8):1707-15. PubMed ID: 9605579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]